HIMS 全部观点

HIMS 这一页 5 条观点条目,其中 0 条方向发生变化。

在本页筛选
The Hims & Hers Australia Strategy: Why It Matters for Investors
$HIMS看涨
HIMS是一个高增长的非对称投资案例;若成为全球医疗需求聚合者,其价值可能增长10至100倍。

作为美国领先的远程医疗公司,对 Hims & Hers 来说可能是一个 10 倍的机会,甚至更大,但成为全球远程医疗公司——无论你身在何处,都能回答你所有问题的地方——才是医疗保健和 Hims & Hers 真正巨大的机会所在。

Being a leading telehealth company in the US could be a 10x, maybe even a bigger opportunity for Hims & Hers, but beating being the global telehealth company where you go to answer all your questions no matter where you are in the world is really where the massive opportunity is for healthcare and for Hims & Hers.

我认为这就是我们在 Hims & Hers 身上看到的情况,而且该公司本周早些时候发布的一份简短说明,在很大程度上揭示了他们如何看待长期建设这项业务。

I think that's what we're seeing with Hims & Hers and there is a small note that the company released early in the week this week that tells a lot about how they're viewing building out that business long-term.

更早的记录
Financial Education发布 2026-08-24
This Stock will make us RICH🤑AF
$HIMS未站边
HIMS面临频繁的负面消息,持有需要坚定信念以避免被震出局。

第一,我们将在本视频中讨论Hims股票,好吗?有一些关于Hims的消息传出来。股价大幅下跌。我想谈谈这个。

Number one, we're going to discuss Hims stock in this video, okay? There was some news that came out in regards to Hims. Stock went down heavy. I want to talk about that.

Hims股票今天在这里遭到重创,下跌约8%,对吧?对Hims股票来说是艰难的一天。在我观察名单上的股票中,你知道,4000xstocks.com,这是今天表现最差的。

Hims stock got hammered here today, down 8% roughly, right? Tough day for Hims stock. Of the stocks on my watchlist, you know, 4000xstocks.com, that was the worst performer here today.

所以,Hims过去一年过得很艰难。股价在过去一年下跌了30%。不过,它从十几美元的低点反弹了不少,但总体而言,它只是经历了非常艰难的一年,对吧?

So, Hims has had a tough past year. Stock is down 30% over the past year. It's up quite a bit from the lows it reached at the high teens, though, but it's overall, it's just had a very tough year, right?

更早的记录
4 Incredible Stocks I Love Today
$HIMS看涨
Hims & Hers是一只长期成长股,潜力强劲,其营收增长重新加速、订阅用户增长以及利润率扩张机会为其提供了支撑。

Hims & Hers,尽管今年经历了这一切,实际上今年仍下跌近 20%,但你可以看到股价在 2 月底触底。自那以来,上涨近 100%,仅小幅回调。他们在 7 月初的交易价格接近每股 40 美元。

所以,自那以来,下跌约 25%。这是一只波动性很大的股票。所以,投资者需要记住这一点。

Hims & Hers, as for everything that it has gone through this year, is actually still down almost 20% for the year, but you can see shares bottomed in late February. Since then, up nearly 100% pulled back just a little bit. They were trading at nearly $40 per share in early July. So, since then, down about 25%. Very volatile stock. So, something to keep in mind for investors.

Financial Education发布 2026-08-10
This Stock is Next to make NEW$millionaires‼️
$HIMS未站边
Hims具有长期潜力,但近期财务状况疲弱;将其列入观察名单而非立即买入。

但是,有一只我感兴趣想买入的股票,它就在我的观察名单上,那就是 Hims。Hims 的股票,明白吗?这是我可能想要建仓的一只股票,现在股价就在 30 美元多一点,对吧?而且我已经把它列入了我的买入观察名单,对吧?

But, there's is a stock that I've been interested in buying, and it's right on my watch list, and it is Hims. Hims stock, okay? This is one I've been interested in potentially starting a position, and it's 30, you know, just over $30 right now, right? And I got it on my stocks to buy watch list, right?

嗯,Hims 这里我们有点问题,明白吗?他们刚刚发布了最新的业绩。现在,营收看起来不错,增长了 38%。很棒。但这份报告有很多问题,明白吗?现在,其中一些问题与重组、GLP、摆脱复合药物有关。

$HIMS: Paul Cerro wouldn't trust the CEO to walk his dog. He's still long. Why? | Cedar Grove
$HIMS看涨
看多Hims,论点基于其向数据/留存业务的转型以及国际增长,这些因素超过了管理层信任问题和当前估值担忧。

今天,我第二次邀请 Paul Cerro 做客。Paul 经营 Cedar Grove Capital,他对 Hims 有一个投资论点。股票代码是 Hims。

today I've got Paul Cerro on for the second time. Paul runs Cedar Grove Capital and he has a thesis on Hims. The ticker is Hims.

他曾在一家 Hims 的竞争对手公司工作,因此他拥有实际的行业专业知识,而且他写过一篇分析,这是他第三次撰写并交易该股票。他做多该股取得了巨大成功,做空该股也取得了巨大成功,现在他又做多了。

He used to work for a Hims competitor, so he's got a you know, actual sector expertise and this is like he's done a write-up on This is his third time he's written up gone traded kind of quote-unquote traded the stock. He went long the stock to great success. He went short the stock to great success and now he's long the stock again.

已经是最早的记录
其他股票的全部观点条目
把 $HIMS 加入我的股票30 天完整试用
开始试用